Representatives from the AADA, leading dermatologists, and researchers testified prior to the panel highlighting the risks associated with indoor tanning and the need to protect the public from these risks. Following the hearing, the AADA has been working with the FDA closely, and both condition and federal legislatures to safeguard minors from the hazards of indoor tanning. With a reclassification, tanning bed and lamp producers will be required to show that their products have met certain efficiency testing requirements. Furthermore, tanning bed and lamp producers will be asked to label the gadgets so that they: -clearly inform customers about the dangers of using tanning beds; -warn regular users of sunlamps to be screened for pores and skin cancer regularly; and, -alert users that tanning lamps are not recommended for folks under 18 years older.Tax provision was $3.8 million, compared to $4.9 million for the same period in the last year. Related StoriesEnvironmental elements may lead to advancement of some childhood cancersUnited Cannabis files utility and PCT patent applications linked to unique specs of cannabinoidsScientists map out the brain circuitry critical for filtering out distractions Balance Sheet At March 31, 2014, Alkermes had money and total investments of $701.8 million, compared to $450.0 million at Dec. 31, 2013. Investments and Money at March 31, 2014 included gross proceeds of $250.0 million linked to the sale of 5,917,160 of Alkermes' regular shares to Invesco Perpetual Money through a registered immediate offering, which closed on Jan. 16, 2014. At March 31, 2014, the organization's total personal debt outstanding was $362.7 million.